ML-104

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameML-104

Drug Alias NameBMMPIs (H Lee Moffitt Cancer Center and Research Institute)MMP2 inhibitors (H Lee Moffitt Cancer Center and Research Institute)ML-115ML-104

ClassificationSmall molecules

Mechanisms of ActionMatrix metalloproteinase-2 inhibitors

TargetsMatrix metalloproteinase-2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesItaly

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesH Lee Moffitt Cancer Center & Research Institute

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversità Degli Studi Di Bari Aldo Moro H Lee Moffitt Cancer Center & Research Institute

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A